Latest Headlines

31. IPN Develops Innovative Rapid Test To Diagnose Childhood Leukemia 8/24/2025

    Researchers at the Instituto Politécnico Nacional (IPN) are developing a rapid test to detect childhood acute lymphoblastic leukemia, wto minimizethe use of invasive methods such as bone marrow biopsies and promote early diagnosis so that treatment can begin promptly.

32. New Sensor Is A Breath Of Fresh Air For Diagnosing Diabetes 8/22/2025

    In the U.S., one in five of the 37 million adults who has diabetes doesn’t know it. Current methods of diagnosing diabetes and prediabetes usually require a visit to a doctor’s office or lab work, both of which can be expensive and time-consuming.

33. Thermo Fisher Scientific Opens Manufacturing Center Of Excellence Site In North Carolina 8/21/2025

    Thermo Fisher Scientific Inc., the world leader in serving science, today announced the grand opening of its innovative manufacturing center of excellence facility in Mebane, N.C.

34. DiamiR Biosciences And Aptorum Group Announce New York State Approval For DiamiR's APOE Genotyping Test 8/21/2025

    DiamiR Biosciences Corp. (“DiamiR”), a developer of innovative blood-based diagnostic tests for brain health and other diseases, and Aptorum Group Limited (NASDAQ: APM) ("Aptorum Group” or “Aptorum”), a clinical stage biopharmaceutical company dedicated to addressing unmet medical needs, today announced that DiamiR received a Clinical Laboratory Evaluation Program (CLEP) Test Approval for its APOE Genotyping test from the New York State Department of Health (NYSDOH).

35. Quanterix Accelerator Laboratory Awarded Rigorous New York State Clinical Laboratory Permit 8/21/2025

    Quanterix Corporation, a company fueling scientific discovery through ultrasensitive biomarker detection, today announced the New York State Department of Health (NYSDOH) has granted the Quanterix Accelerator Laboratory a clinical laboratory permit in the Clinical Chemistry category.

36. PathAI And Moffitt Cancer Center Announce Strategic Collaboration To Deploy The AISight Dx Digital Pathology Platform And Advance AI Diagnostics 8/21/2025

    PathAI, a global leader in artificial intelligence and digital pathology solutions, and Moffitt Cancer Center, one of the nation’s top cancer hospitals and a leader in cancer research, today announced a multi-year strategic collaboration to deploy PathAI’s digital pathology platform, AISight Dx, across Moffitt’s pathology programs to transform cancer detection and innovation.

37. ISS National Lab-Sponsored Experiment Tests 3D Bioprinted Tissue For Growing Artificial Livers 8/20/2025

    To explore how 3D bioprinted liver tissue constructs complete with vascular channels behave in microgravity, the Wake Forest Institute for Regenerative Medicine (WFIRM) is sending an investigation to the International Space Station (ISS).

38. Agilent MMR IHC Panel pharmDx (Dako Omnis) Receives FDA Approval As A Companion Diagnostic Test For Colorectal Cancer 8/20/2025

    Agilent Technologies Inc. today announced that its MMR IHC Panel pharmDx (Dako Omnis) has received FDA approval as a companion diagnostic (CDx) test for colorectal cancer.

39. LabConnect Launches LabConnector^™ To Streamline Lab Data Integration 8/19/2025

    LabConnect, LLC, a global leader in central laboratory services for clinical trials, today announced the launch of LabConnector^™, a powerful new technology solution that transforms the way laboratory data is exchanged and managed for clinical trials.

40. Ultima Genomics And Gene By Gene Partner To Expand Global Access To High-Quality, Low-Cost Sequencing On The UG 100™ Platform 8/19/2025

    Ultima Genomics, Inc., developer of the UG 100™ next-generation sequencing (NGS) platform, and Gene by Gene, a leading global provider of advanced genetic testing and genomic services, today announced a partnership to broaden worldwide access to high-quality, cost-effective DNA sequencing.